Biopol Chemicals IPO Details 2026

Biopol Chemicals IPO is a book-built public issue with a total size of ₹31.26 crore, aimed at raising capital to support the company’s growth plans and business expansion.

The IPO consists of Fresh Issue, offering investors an opportunity to participate in the company’s future journey through listing on the NSE SME stock exchange.

The IPO opened for subscription on Feb 06, 2026, and closed on Feb 10, 2026. The basis of allotment was finalized on Feb 11, 2026, and the equity shares were subsequently listed on NSE SME stock exchange at Feb 13, 2026.

IPO Open

Feb 06, 2026 - Feb 10, 2026

Price Band

₹102.00 - ₹108.00

Listing

On NSE SME at Feb 13, 2026

Market Cap (Pre-IPO)

₹116.7 Cr.

Biopol Chemicals IPO Details

Face Value ₹10.00 per share
Price Band ₹102.00 - ₹108.00
Lot Size 1,200 Shares
Sale Type Fresh Issue
Issue Type Book Building
Listing Exchange(s) NSE SME
Total Issue Size ₹31.26 Cr
Reserved for Market Maker ₹1.63 Cr
Market Maker Shreni Shares Ltd.
Net Offered to Public ₹29.63 Cr
Fresh Issue ₹29.63 Cr
Share Holding Pre Issue 79,11,000
Share Holding Post Issue 1,08,05,400
Promoter Holding Pre IPO 89.88
Promoter Holding Post IPO 65.81

Biopol Chemicals IPO Time Table (Tentative)

Opening Date Feb 06, 2026
Closing Date Feb 10, 2026
Allotment Date Feb 11, 2026
Refund Date Feb 12, 2026
Credit of Shares in Demate Account Feb 12, 2026
Listing Date Feb 13, 2026

Biopol Chemicals IPO Lot Size

Investor Type Lots Shares Amount
Retail (Min) 2 2,400 ₹2,59,200
Retail (Max) 2 2,400 ₹2,59,200
S-HNI (Min) 3 3,600 ₹3,88,800
S-HNI (Max) 7 8,400 ₹9,07,200
B-HNI (Min) 8 9,600 ₹10,36,800

Biopol Chemicals IPO Reservation

Investor Category Shares Offered
Market Maker Shares Offered 1,51,200
QIB Shares Offered 6,86,400
NII (HNI) Shares Offered 10,94,400
    − bNII > ₹10L 7,29,600
    − sNII < ₹10L 3,64,800
Retail Shares Offered 9,62,400
Total Shares Offered 28,94,400

About Biopol Chemicals Ltd.

Company Overview

Established in 2023, Biopol Chemicals Limited operates in the specialty chemicals segment, focusing on the production and supply of value-added chemical solutions. The company’s offerings are broadly classified into silicones, emulsifiers, biochemicals, and polyelectrolytes, catering to diverse industrial requirements.


Business Model

Biopol Chemicals follows a B2B business model, serving institutional and industrial customers rather than end-consumers. Its products are supplied to clients across multiple sectors, including textiles, home care, agriculture, and industrial applications.


Product Portfolio

The company has developed a wide product range consisting of 66 specialty chemical formulations, segmented as follows:

  • Silicone-based products: 40 variants

  • Emulsifier-based products: 5 variants

  • Biochemical products: 15 variants

  • Polyelectrolyte products: 6 variants

These products are designed to enhance performance, efficiency, and durability in their respective applications.


Application Segments

  • Textile Chemicals: Softeners, silicones, emulsions, hydrophilic finishes, binders, hardeners, and dyeing & printing auxiliaries

  • Home Care Solutions: Silicone fluids, emulsifiers, and specialty cleaning chemicals

  • Agricultural Inputs: Silicone adjuvants and surfactants

  • Industrial Chemicals: Silicone-based release agents and specialty PVC lubricants


Manufacturing & Infrastructure

Biopol Chemicals operates through four establishments across Gujarat and West Bengal. These include:

  • A manufacturing facility, corporate office, and warehouse in West Bengal

  • A registered office in Gujarat

The manufacturing unit has an installed production capacity of approximately 18.25 lakh litres per annum.


Human Resources

As of December 31, 2025, the company employed 24 personnel across operations, quality control, administration, and management functions.


Competitive Strengths

  • Healthy order book supporting revenue visibility

  • In-house manufacturing capabilities

  • Strong quality control systems and certifications

  • Strategic operational presence in Gujarat and West Bengal

  • Experienced promoters and management team

  • Established export presence in Bangladesh

Biopol Chemicals Ltd. Financials (Restated Consolidated)

Quarter Assets Total Income Profit After Tax EBITDA NET Worth Reserves and Surplus Total Borrowing
Dec 31, 2025 48.88 48.97 6 8.99 19.54 11.63 14.92
Mar 31, 2025 31.48 49.15 4.33 6.53 13.53 5.62 7.69
Mar 31, 2024 17.56 17.43 2.96 4.43 9.2 1.29 3.58
Amount in ₹ Crore

Biopol Chemicals Ltd. Live GMP**

GMP Date IPO Price GMP Estimated Listing Price Rating
Feb 02, 2026 ₹108 ₹0 ₹108
(0%)
🔥
* Estimated Profit/Loss per lot. GMP * MARKET LOT.

Biopol Chemicals IPO Objects

# Issue Objects Estimate Amount (₹ Cr.)
1 Acquisition of industrial land 12.26
2 Repayment in full or in part, of borrowings availed by the Company from banks, financial institutions and non-banking financial companies 11.1
3 General Corporate Purposes 0

Company Contact Details

  • Biopol Chemicals Ltd.
  • D-211, 2nd Floor, Block-D, Sumel Business Park-6 Near Dudheshwar Circle Dudheshwar Tavdipura
    Ahmedabad, Gujarat, 380004
  •   +91- 9147076778
  •   investors@biopolchemicals.com
  •   Visit Website